Abstract
Pioneering research in the genetic manipulation of Mycobacterium, such as performed by Jacobs Jr et al. allowed the introduction of foreign DNA into Mycobacterium smegmatis and BCG.11 This opened the possibility for development of multi-vaccines based on BCG as a live vehicle to present heterologous antigens from different pathogens. Since then, several groups have had success in the development of rBCG strains, expressing antigens from virus, bacteria or parasites, or even cytokine molecules.1,2,12 Despite several reports on the successful construction of rBCG strains, many rBCG constructs did not attain expression, revealing the importance of characterising other expression vectors construct. On the other hand, there are studies that have indicated a role for antigen expression level in the induction of immune responses. For the Mycobacterium tuberculosis (Mtb) antigen, 85B, low-level expression skewed the immune response towards a T helper 1 (Th1) immune response, and higher expression levels towards a Th2 immune response.13

This publication has 32 references indexed in Scilit: